AS
REGN icon

Aware Super’s Regeneron Pharmaceuticals REGN Stock Holding History

Aware Super’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.72M Buy
15,585
+11,782
+310% +$8.02M 0.14% 133
2026
Q1 		$2.94M Buy
+3,803
New +$2.91M 0.04% 194
2025
Q3 		$634K Hold
1,128
– – 0.01% 220
2025
Q2 		$592K Sell
1,128
-1,949
-63% -$1.09M 0.01% 224
2025
Q1 		$1.95M Hold
3,077
– – 0.03% 211
2024
Q4 		$2.19M Buy
+3,077
New +$2.58M 0.04% 208
2023
Q4 		$3.08M Buy
+3,995
New +$3.29M 0.04% 197

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Aware Super's REGN Position: Q2 2026 in Review

Aware Super increased its Regeneron Pharmaceuticals (REGN) stake by 310% in Q2 2026, buying an estimated $8.02M and bringing the position to 15,585 shares worth $9.72M. The position accounts for 0.14% of the portfolio, ranked #133.

Aware Super first reported a position in REGN in Q4 2023 and has held it in 7 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Aware Super held 15,585 shares of Regeneron Pharmaceuticals worth $9.72M as of Q2 2026.
  • Aware Super bought 11,782 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.02M.
  • Regeneron Pharmaceuticals made up 0.14% of Aware Super's portfolio in Q2 2026, its #133 holding.
  • Aware Super first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.